Historical record - last NADAC effective date: 6/19/2024
Product Information
MUCINEX FAST-MAX DM MAX LIQUID is a brand product labeled by RB Health (US) LLC, priced at $0.0614 per ML under NDC 63824001966. Its NADAC has been published 434 times since Oct 1, 2014.
Strength
20; 400 mg/20mL; mg/20mL
Manufacturer
RB Health (US) LLCNDC
63824001966
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/18/2012
Pharmacological Classes
Price Statistics
The NADAC for MUCINEX FAST-MAX DM MAX LIQUID has been published 434 times since Oct 1, 2014, and over the history we have for it it has risen 33.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0614 per ML |
|---|---|
| All-time high | $0.0639 (Jun 29, 2022) |
| All-time low | $0.0458 (Feb 18, 2015) |
| Median price | $0.0527 |
| Average price | $0.0524 |
| Largest weekly change | +16.7% (Apr 6, 2022) |
| Weeks tracked | 434 |
| Tracking since | Oct 1, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-4.0%
5Y
+15.4%
All
+33.8%
Last surveyed Jul 3, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextromethorphan hydrobromide and guaifenesin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
RB Health (US) LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextromethorphan hydrobromide and guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUCINEX FAST-MAX DM MAX LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for MUCINEX FAST-MAX DM MAX LIQUID, manufactured by RB Health (US) LLC, is $0.0614 per ML (NDC 63824001966), effective Jul 3, 2024.
How has the price of MUCINEX FAST-MAX DM MAX LIQUID changed over time?
Over the history we have for it, the NADAC for MUCINEX FAST-MAX DM MAX LIQUID has risen 33.8%. It has been tracked across 434 weekly CMS publications since Oct 1, 2014.
What are the highest and lowest recorded NADAC prices for MUCINEX FAST-MAX DM MAX LIQUID?
Since Oct 1, 2014, the NADAC for MUCINEX FAST-MAX DM MAX LIQUID has ranged from a low of $0.0458 (Feb 18, 2015) to a high of $0.0639 (Jun 29, 2022), with a median of $0.0527 per ML.
Are there cheaper alternatives to MUCINEX FAST-MAX DM MAX LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of MUCINEX FAST-MAX DM MAX LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MUCINEX FAST-MAX DM MAX LIQUID?
MUCINEX FAST-MAX DM MAX LIQUID (NDC 63824001966) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.